Overview

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Status:
Completed
Trial end date:
2021-09-08
Target enrollment:
Participant gender:
Summary
A 12 month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.
Phase:
Phase 3
Details
Lead Sponsor:
Radius Health, Inc.
Treatments:
Abaloparatide
Parathyroid Hormone-Related Protein